CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+5.12%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.78B
AUM Growth
+$56.1M
(+0.98%)
Cap. Flow
-$211M
Cap. Flow
% of AUM
-3.66%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
798
New
72
Increased
310
Reduced
286
Closed
45
Top Buys
| 1 |
Amgen
AMGN
|
+$28M |
| 2 |
Meta Platforms (Facebook)
META
|
+$25.9M |
| 3 |
Southwest Airlines
LUV
|
+$18.5M |
| 4 |
Travelers Companies
TRV
|
+$17.6M |
| 5 |
Cigna
CI
|
+$16.9M |
Top Sells
| 1 |
Biogen
BIIB
|
+$75.9M |
| 2 |
Johnson & Johnson
JNJ
|
+$27.9M |
| 3 |
Gilead Sciences
GILD
|
+$25M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$22.7M |
| 5 |
Amazon
AMZN
|
+$21.4M |
Sector Composition
| 1 | Healthcare | 22.62% |
| 2 | Technology | 14.66% |
| 3 | Financials | 14.55% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
301
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.05M | 0.07% |
280,000
+103,000
| +58% | +$1.49M |
|
302
Puma Biotechnology
PBYI
$237M
| $4.05M | 0.07% |
41,000
-16,500
| -29% | -$1.63M |
|
303
Alaska Air
ALK
$7.19B
| $4.03M | 0.07% |
54,762
-84,317
| -61% | -$6.2M |
|
304
Enanta Pharmaceuticals
ENTA
$193M
| $3.99M | 0.07% |
68,000
-157,000
| -70% | -$9.21M |
|
|
AABA
305
DELISTED
Altaba Inc. Common Stock
AABA
| $3.98M | 0.07% |
56,984
-26,063
| -31% | -$1.82M |
|
306
AnaptysBio
ANAB
$618M
| $3.98M | 0.07% |
+39,500
| New | +$3.98M |
|
307
Walmart
WMT
$816B
| $3.93M | 0.07% |
119,433
-4,308
| -3% | -$142K |
|
308
lululemon athletica
LULU
$19.6B
| $3.92M | 0.07% |
49,877
-8,397
| -14% | -$660K |
|
|
MIC
309
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $3.91M | 0.07% |
60,971
-85,675
| -58% | -$5.5M |
|
310
Lam Research
LRCX
$134B
| $3.91M | 0.07% |
212,470
+69,010
| +48% | +$1.27M |
|
311
eBay
EBAY
$42.3B
| $3.88M | 0.07% |
102,789
+1,827
| +2% | +$68.9K |
|
312
Karyopharm Therapeutics
KPTI
$55.7M
| $3.87M | 0.07% |
26,867
-7,133
| -21% | -$1.03M |
|
313
Dominion Energy
D
$50.2B
| $3.85M | 0.07% |
47,439
+4,885
| +11% | +$396K |
|
314
Scotiabank
BNS
$79.2B
| $3.81M | 0.07% |
58,828
+7,040
| +14% | +$456K |
|
315
Kimberly-Clark
KMB
$43.5B
| $3.79M | 0.07% |
31,416
-7,049
| -18% | -$851K |
|
316
Roper Technologies
ROP
$55.9B
| $3.73M | 0.06% |
14,399
+4,406
| +44% | +$1.14M |
|
317
Take-Two Interactive
TTWO
$45.7B
| $3.73M | 0.06% |
33,941
-54,506
| -62% | -$5.98M |
|
318
Zoetis
ZTS
$66.4B
| $3.7M | 0.06% |
51,285
+122
| +0.2% | +$8.79K |
|
319
American International
AIG
$43.5B
| $3.69M | 0.06% |
61,852
-1,507
| -2% | -$89.8K |
|
320
CME Group
CME
$94.3B
| $3.67M | 0.06% |
25,110
+1,393
| +6% | +$203K |
|
|
IMGN
321
DELISTED
Immunogen Inc
IMGN
| $3.65M | 0.06% |
570,000
| – | – |
|
322
Labcorp
LH
$23.1B
| $3.61M | 0.06% |
26,363
-879
| -3% | -$120K |
|
323
Baxter International
BAX
$12.6B
| $3.58M | 0.06% |
55,419
-16,635
| -23% | -$1.08M |
|
324
CSX Corp
CSX
$60B
| $3.57M | 0.06% |
194,571
+3,252
| +2% | +$59.6K |
|
325
Kraft Heinz
KHC
$31.6B
| $3.57M | 0.06% |
45,827
-1,451
| -3% | -$113K |
|